Biogen Inc. (BIIB)

Trade BIIB now with
12/4/2017 7:31:31 AM Biogen Appoints Mark Hernon As SVP, Chief Information Officer, Effective December 4
11/27/2017 7:00:48 AM Biogen And Alkermes Announce License And Collaboration Agreement To Develop And Commercialize ALKS 8700
11/21/2017 7:44:11 AM Biogen Names Jeff Capello CFO
11/21/2017 7:31:39 AM Biogen Appoints Jeffrey Capello As EVP And CFO
11/2/2017 4:31:54 PM Biogen Appoints Chirfi Guindo As EVP And Head Of Global Marketing, Market Access And Customer Innovation
11/2/2017 7:35:19 AM Biogen To Present New Data From Long-term Extension Of Ongoing Phase 1b Study Of Aducanumab
11/1/2017 5:08:18 PM Biogen And Ionis Announce Publication Of End Of Study Results From ENDEAR, The Phase 3 Study Of SPINRAZA
10/25/2017 1:00:56 AM Biogen Announces AFFINITY Phase 2 Trial Initiation For Opicinumab (Anti-LINGO-1) In Multiple Sclerosis
10/24/2017 7:04:02 AM Biogen Inc. Q3 Earnings Rise 25%
10/24/2017 6:59:49 AM Biogen Q3 Non-GAAP EPS $6.31
10/24/2017 6:30:00 AM Biogen Announces Amended Agreement With Neurimmune Holding AG
10/23/2017 7:17:13 AM Biogen And Eisai Expand Existing Agreement To Jointly Develop Investigational Alzheimer’s Disease Treatments
10/18/2017 7:31:17 AM Biogen Confirms Comprehensive Approach To Tackle Multiple Sclerosis